-
The Latest AI Can Work Things Out Without Being Taught
Oct 18, 2017, 17:02 PM by Michael CroftThe Economist | IN 2016 Lee Sedol, one of the world's best players of Go, lost a match in Seoul to a computer program called AlphaGo by four games to one. It was a big event, both in the history of Go and in the history of artificial intelligence.Full story -
How To Spend $1900 On Gene Tests Without Learning A Thing
Oct 18, 2017, 09:15 AM by Michael CroftMIT Technology Review | Science and marketing clash in the "jungle" of direct-to-consumer DNA apps.Full story -
What’s new at Lab Innovations 2017
Oct 18, 2017, 03:53 AM by Michael CroftBIRMINGHAM, ENGLAND - Oct 18, 2017 - Now in its sixth consecutive year, the showcase promises an array of new and exciting attractions for 2017, developed to cater to the broad needs of visitors to the UKs only dedicated event for laboratory, analytical and biotech equipmentFull story -
New European Council of regulatory professionals set to shape and support the profession
Oct 17, 2017, 11:34 AM by Michael Croft- Oct 17, 2017 - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and supporting its European expansion with the launch of its first ever RAPS European Council (REC)Full story -
GA4GH Announces New Strategic Plan, Vision To Create Standards
Oct 17, 2017, 11:00 AM by Michael CroftFull storyBio-IT World | At a plenary session this morning in Orlando, Florida, the Global Alliance for Genomics and Health (GA4GH) announced a new vision and five-year strategic plan: GA4GH Connect, aiming to drive uptake of GA4GH standards and frameworks for genomic data discovery, analysis, and interpretation in order to enable responsible sharing of clinical-grade genomic data by 2022.
-
China Welcomes Oxford Nanopore Technology
Oct 17, 2017, 10:45 AM by Michael CroftFull storyBio-IT World Brief | Oxford Nanopore sequencing technology is now available in China. The long-read, real-time, portable MinION sequencer is now being used by researchers across China, who are working on myriad DNA sequencing applications including: pathogen research, human genetics, plant genetics, animal genetics, and metagenomics.
-
BC Platforms Announces Collaborations to Advance Research in Multiple Sclerosis
Oct 17, 2017, 08:03 AM by Michael CroftBASEL, SWITZERLAND AND BOSTON, MASSACHUSETTS - Oct 16, 2017 - BC Platforms, a world leader in genomic data management and analysis solutions, today announces that Biogen and the Accelerated Cure Project (ACP) will each be using its technology solutions and research platform, including its recently launched BCRQUESTFull story -
Illumina Ventures Closes $230 Million Fund
Oct 16, 2017, 12:10 PM by Michael CroftFull storyBio-IT World Brief | Illumina Ventures announced today that it has raised $230 million for its first fund. The balance of the funds have been raised from a mix of corporate, institutional, sovereign, and individual investors.
-
Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
Oct 13, 2017, 14:50 PM by Michael CroftCHAPEL HILL, NC - Oct 13, 2017 - TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Intercept has extended its strategic partnership for TARGET-NASH to a multi-year agreementFull story -
Data Security And Cloud Providers: Assessing The Risks
Oct 13, 2017, 11:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Research organizations are aware of the potential for cloud technologies to increase efficiency, cut costs, and reduce time to market. In the wake of the recent Equifax breach, the latest in a seemingly endless string of security incidents, organizations want to ensure they are protecting their assets and minimizing potential liabilities.
-
Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
Oct 12, 2017, 11:24 AM by Michael CroftCHAPEL HILL, NC - Oct 12, 2017 - TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic partnership for TARGET-NASH to a multi-year agreementFull story -
FDA Vote Sets Stage For Gene Therapy’s Future
Oct 12, 2017, 09:14 AM by Michael CroftMIT Technology Review | A first-of-its-kind medical treatment that replaces a mutated gene with a correct copy could soon be available in the U.S.Full story -
Elsevier donates Unified Data Model to The Pistoia Alliance, facilitating data sharing and accelerating research in the life sciences
Oct 12, 2017, 05:03 AM by Michael CroftNEW YORK, NY - Oct 10, 2017 - Elsevier, the information analytics business specializing in science and health, has announced it is donating its Unified Data Model (UDM) to The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&DFull story -
MDI Biological Laboratory Scientist Vicki P. Losick, Ph.D., Recognized As ‘Outstanding Investigator’
Oct 11, 2017, 15:49 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Oct 11, 2017 - Vicki P. Losick, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine, has been recognized as an outstanding investigator by the National Institute of General Medical Sciences, an institute of the National Institutes of Health (NIH), for her research on wound healingFull story -
The Future Of DNA Sequencing
Oct 11, 2017, 13:26 PM by Michael CroftNature News & Comment | Eric D. Green, Edward M. Rubin, and Maynard V. Olson speculate on the next forty years of DNA sequencing, from policing to data storage.Full story -
What The EU General Data Protection Regulation Means For You
Oct 10, 2017, 09:15 AM by Michael CroftFull storyBio-IT World | The European Union’s General Data Protection Regulation goes into effect May 25, 2018. The regulation is significantly more expansive than the privacy directive it replaces and carries hefty financial penalties for non-compliance. But the biggest cause for concern may be its impact for non-European companies, who have no idea that the regulations apply to them.
-
Optibrium Joins EUR 40 Million eTRANSAFE project
Oct 10, 2017, 06:02 AM by Michael CroftCAMBRIDGE, UK - Oct 10, 2017 - Optibrium, a developer of software for small molecule drug discovery, today announced that it will join the Enhancing Translational Safety Assessment through Integrative Knowledge Management (eTRANSAFE) projectFull story -
Launch of Next-Generation Clinical Trial Data Platform
Oct 10, 2017, 01:25 AM by Michael CroftRUTLAND, MA, UNITED STATES - Oct 10, 2017 - A brand new clinical trial database and collaborative platform was launched on the 3rd of October, with the aim of being the leading source for every clinical trial data needFull story -
4D Movies Reveal Two Mechanisms For DNA Loops
Oct 6, 2017, 10:40 AM by Michael CroftFull storyBio-IT World | A paper published yesterday in Cell sheds more light on two mechanisms of DNA folding within the nucleus, and how the folding impacts genome function.
-
Illumina Introduces Nextera DNA Flex
Oct 6, 2017, 08:40 AM by Michael CroftFull storyBio-IT World Brief | Illumina announced the availability of an innovative whole genome sequencing library prep product, Nextera DNA Flex, which eliminates the need for sample preparation for whole blood and saliva, and removes tedious steps in the library prep workflow, such as mechanical fragmentation of DNA, quantification, and normalization.